On this page
Advil
ibuprofen · Capsule, Liquid Filled
Overview
Active ingredients
Source: NDC Directory| Ingredient | Strength | RxCUI | Monograph |
|---|---|---|---|
| Ibuprofen | 200 mg/1 | 310965 | View |
Forms, strengths and routes
Source: NDC DirectoryPharmacologic classes are listed in the class section below.
Pharmacologic class
Source: NDC Directory| Class | Type | Browse |
|---|---|---|
| Anti-Inflammatory Agents | EPC | All 251 members |
| Cyclooxygenase Inhibitors [MoA] | MoA | All 251 members |
| Non-Steroidal [CS] | CS | All 251 members |
| Nonsteroidal Anti-inflammatory Drug [EPC] | EPC | All 251 members |
Regulatory status
Source: Drugs@FDANDC Directory| Product | Trade name | Form | Strength | Ingredient | Status | TE | Flags |
|---|---|---|---|---|---|---|---|
| 020402-001 | ADVIL LIQUI-GELS | CAPSULE | IBUPROFEN | Over-the-counter | — | RLD RS | |
| 020402-002 | ADVIL MIGRAINE LIQUI-GELS | CAPSULE | IBUPROFEN | Over-the-counter | — | RLD RS |
Therapeutic equivalence
Source: Orange BookCodes beginning with “A” indicate products the FDA considers therapeutically equivalent. Codes beginning with “B” indicate bioequivalence has not been established. See methodology.
Approval history
Source: Drugs@FDA| Type | No. | Action | Status | Date | Review |
|---|---|---|---|---|---|
| Supplement | 58 | Labeling | Approved | January 8, 2025 | Standard |
| Supplement | 55 | Labeling | Approved | February 23, 2023 | Standard |
| Supplement | 53 | Labeling | Approved | January 25, 2022 | Standard |
| Supplement | 47 | Labeling | Approved | August 31, 2018 | Standard |
| Supplement | 46 | Labeling | Approved | August 2, 2018 | Standard |
| Supplement | 44 | Manufacturing (CMC) | Approved | October 18, 2017 | Standard |
| Supplement | 43 | Labeling | Approved | August 8, 2017 | Standard |
| Supplement | 42 | Manufacturing (CMC) | Approved | March 8, 2017 | N/A |
| Supplement | 40 | Manufacturing (CMC) | Approved | December 17, 2015 | Standard |
| Supplement | 39 | Manufacturing (CMC) | Approved | September 12, 2014 | Standard |
| Supplement | 37 | Manufacturing (CMC) | Approved | December 11, 2012 | Standard |
| Supplement | 36 | Manufacturing (CMC) | Approved | December 5, 2012 | Standard |
| Supplement | 27 | Labeling | Approved | April 20, 2011 | Standard |
| Supplement | 26 | Manufacturing (CMC) | Approved | July 9, 2009 | N/A |
| Supplement | 25 | Labeling | Approved | May 19, 2009 | Standard |
| Supplement | 24 | Labeling | Approved | June 11, 2008 | Standard |
| Supplement | 16 | Labeling | Approved | April 28, 2006 | Standard |
| Supplement | 18 | Labeling | Approved | February 8, 2006 | Standard |
| Supplement | 11 | Labeling | Approved | February 26, 2004 | Standard |
| Supplement | 7 | Manufacturing (CMC) | Approved | August 2, 2001 | Standard |
| Supplement | 6 | Manufacturing (CMC) | Approved | March 28, 2000 | Standard |
| Supplement | 5 | Efficacy | Approved | March 16, 2000 | Standard |
| Supplement | 4 | Manufacturing (CMC) | Approved | April 9, 1999 | Standard |
| Supplement | 3 | Manufacturing (CMC) | Approved | February 5, 1999 | Standard |
| Supplement | 2 | Labeling | Approved | February 23, 1998 | Standard |
| Supplement | 1 | Manufacturing (CMC) | Approved | October 6, 1997 | Standard |
| Original application | 1 | Type 3 - New Dosage Form | Approved | April 20, 1995 | Standard |
Review documents
- 0 · Supplement · September 23, 2025
- 0 · Supplement · January 10, 2025
- 0 · Supplement · February 24, 2023
- 0 · Supplement · February 24, 2023
- 0 · Supplement · February 3, 2022
- 0 · Supplement · September 14, 2018
- 0 · Supplement · September 13, 2018
- 0 · Supplement · August 3, 2018
- 0 · Supplement · August 3, 2018
- 0 · Supplement · October 19, 2017
- 0 · Supplement · August 15, 2017
- 0 · Supplement · August 15, 2017
- 0 · Supplement · August 1, 2017
- 0 · Supplement · August 1, 2017
- 0 · Supplement · December 22, 2015
- 0 · Supplement · December 18, 2015
- 0 · Supplement · July 9, 2015
- 0 · Supplement · April 22, 2011
- 0 · Supplement · July 15, 2009
- 0 · Supplement · May 26, 2009
- 0 · Supplement · June 17, 2008
- 0 · Supplement · May 2, 2006
- 0 · Supplement · February 22, 2006
- 0 · Supplement · February 27, 2004
- 0 · Supplement · July 8, 2003
- 0 · Supplement · March 16, 2000
- 0 · Supplement · March 16, 2000
Prescribing information
Source: openFDA Drug LabelingReproduced verbatim from the Structured Product Labeling submitted to the FDA (effective 20260729). This is the manufacturer's labelling text, not a summary and not advice.
Indications and Usage
openFDA Drug LabelingUses temporarily relieves minor aches and pains due to: headache toothache backache menstrual cramps the common cold muscular aches minor pain of arthritis temporarily reduces fever
Purpose
openFDA Drug LabelingPurpose Pain reliever/Fever reducer
Dosage and Administration
openFDA Drug LabelingDirections do not take more than directed the smallest effective dose should be used adults and children 12 years and over: take 1 capsule every 4 to 6 hours while symptoms persist if pain or fever does not respond to 1 capsule, 2 capsules may be used do not exceed 6 capsules in 24 hours, unless directed by a doctor children under 12 years: ask a doctor
Warnings
openFDA Drug LabelingWarnings Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include: hives facial swelling asthma (wheezing) shock skin reddening rash blisters If an allergic reaction occurs, stop use and seek medical help right away. Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you are age 60 or older have had stomach ulcers or bleeding problems take a blood thinning (anticoagulant) or steroid drug take other drugs containing prescription or nonprescription NSAIDs [aspirin, ibuprofen, naproxen, or others] have 3 or more alcoholic drinks every day while using this product take more or for a longer time than directed Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed. Do not use if you have ever had an allergic reaction to any other pain reliever/fever reducer right before or after heart surgery Ask a doctor before use if stomach bleeding warning applies to you you have problems or serious side effects from taking pain relievers or fever reducers you have a history of stomach problems, such as heartburn you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or had a stroke you are taking a diuretic Ask a doctor or pharmacist before use if you are under a doctor's care for any serious condition taking aspirin for heart attack or stroke, because ibuprofen may decrease this benefit of aspirin taking any other drug When using this product take with food or milk if stomach upset occurs Stop use and ask a doctor if you experience any of the following signs of stomach bleeding: feel faint vomit blood have bloody or black stools have stomach pain that does not get better you have symptoms of heart problems or stroke: chest pain trouble breathing weakness in one part or side of body slurred speech leg swelling pain gets worse or lasts more than 10 days fever gets worse or lasts more than 3 days redness or swelling is present in the painful area any new symptoms appear If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use ibuprofen at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Do Not Use
openFDA Drug LabelingDo not use if you have ever had an allergic reaction to any other pain reliever/fever reducer right before or after heart surgery
Ask a Doctor
openFDA Drug LabelingAsk a doctor before use if stomach bleeding warning applies to you you have problems or serious side effects from taking pain relievers or fever reducers you have a history of stomach problems, such as heartburn you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or had a stroke you are taking a diuretic
Stop Use
openFDA Drug LabelingStop use and ask a doctor if you experience any of the following signs of stomach bleeding: feel faint vomit blood have bloody or black stools have stomach pain that does not get better you have symptoms of heart problems or stroke: chest pain trouble breathing weakness in one part or side of body slurred speech leg swelling pain gets worse or lasts more than 10 days fever gets worse or lasts more than 3 days redness or swelling is present in the painful area any new symptoms appear
Active Ingredient
openFDA Drug LabelingActive ingredient (in each capsule) Solubilized ibuprofen equal to 200 mg ibuprofen (NSAID)* (present as the free acid and potassium salt) *nonsteroidal anti-inflammatory drug
Adverse event reports
Source: openFDA FAERSAttributed to this product's most-reported active ingredient: IBUPROFEN. Combination products with more than six active ingredients are not attributed, because a report count summed across a long ingredient list measures the list, not the medicine.
Recalls
Source: FDA Enforcement| Classification | Reported | Firm | Reason | Status |
|---|---|---|---|---|
| Class II | April 1, 2020 | Glaxosmithkline Consumer Healthcare Holdings | Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel. | Terminated |
Packaging and NDCs
Source: NDC Directory| Package NDC | Product NDC | Labeler | Description | Marketing start |
|---|---|---|---|---|
| 0573-0149-04 | 0573-0149 | Haleon US Holdings LLC | 2 PACKET in 1 BLISTER PACK (0573-0149-04) / 2 CAPSULE, LIQUID FILLED in 1 PACKET | March 1, 2018 |
| 0573-0149-13 | 0573-0149 | Haleon US Holdings LLC | 1 BOTTLE in 1 CARTON (0573-0149-13) / 80 CAPSULE, LIQUID FILLED in 1 BOTTLE | April 10, 1995 |
| 0573-0149-66 | 0573-0149 | Haleon US Holdings LLC | 160 CAPSULE, LIQUID FILLED in 1 BOTTLE (0573-0149-66) | March 1, 2016 |
| 0573-0149-91 | 0573-0149 | Haleon US Holdings LLC | 180 CAPSULE, LIQUID FILLED in 1 BOTTLE (0573-0149-91) | October 1, 2016 |
| 0573-0169-02 | 0573-0169 | Haleon US Holdings LLC | 50 POUCH in 1 BOX (0573-0169-02) / 2 CAPSULE, LIQUID FILLED in 1 POUCH | April 10, 1995 |
| 0573-0169-08 | 0573-0169 | Haleon US Holdings LLC | 2 BOTTLE in 1 CARTON (0573-0169-08) / 120 CAPSULE, LIQUID FILLED in 1 BOTTLE | April 10, 1995 |
| 0573-0169-11 | 0573-0169 | Haleon US Holdings LLC | 1 BOTTLE in 1 CARTON (0573-0169-11) / 120 CAPSULE, LIQUID FILLED in 1 BOTTLE | April 10, 1995 |
| 0573-0169-13 | 0573-0169 | Haleon US Holdings LLC | 240 CAPSULE, LIQUID FILLED in 1 BOTTLE (0573-0169-13) | April 10, 1995 |
| 0573-0169-16 | 0573-0169 | Haleon US Holdings LLC | 2 BOTTLE in 1 CARTON (0573-0169-16) / 80 CAPSULE, LIQUID FILLED in 1 BOTTLE | March 28, 2025 |
| 0573-0169-17 | 0573-0169 | Haleon US Holdings LLC | 3000 POUCH in 1 CASE (0573-0169-17) / 2 CAPSULE, LIQUID FILLED in 1 POUCH | April 10, 1995 |
| 0573-0169-19 | 0573-0169 | Haleon US Holdings LLC | 1 BLISTER PACK in 1 CARTON (0573-0169-19) / 4 CAPSULE, LIQUID FILLED in 1 BLISTER PACK | April 10, 1995 |
| 0573-0169-20 | 0573-0169 | Haleon US Holdings LLC | 1 BOTTLE in 1 CARTON (0573-0169-20) / 20 CAPSULE, LIQUID FILLED in 1 BOTTLE | April 10, 1995 |
| 0573-0169-22 | 0573-0169 | Haleon US Holdings LLC | 1 BOTTLE in 1 CARTON (0573-0169-22) / 30 CAPSULE, LIQUID FILLED in 1 BOTTLE | April 10, 1995 |
| 0573-0169-30 | 0573-0169 | Haleon US Holdings LLC | 1 BOTTLE in 1 CARTON (0573-0169-30) / 40 CAPSULE, LIQUID FILLED in 1 BOTTLE | April 10, 1995 |
| 0573-0169-31 | 0573-0169 | Haleon US Holdings LLC | 1 BOTTLE in 1 CARTON (0573-0169-31) / 60 CAPSULE, LIQUID FILLED in 1 BOTTLE | April 10, 1995 |
| 0573-0169-40 | 0573-0169 | Haleon US Holdings LLC | 1 BOTTLE in 1 CARTON (0573-0169-40) / 80 CAPSULE, LIQUID FILLED in 1 BOTTLE | April 10, 1995 |
| 0573-0169-43 | 0573-0169 | Haleon US Holdings LLC | 1 BOTTLE in 1 CARTON (0573-0169-43) / 120 CAPSULE, LIQUID FILLED in 1 BOTTLE | April 10, 1995 |
| 0573-0169-49 | 0573-0169 | Haleon US Holdings LLC | 200 CAPSULE, LIQUID FILLED in 1 BOTTLE (0573-0169-49) | April 10, 1995 |
| 0573-0169-51 | 0573-0169 | Haleon US Holdings LLC | 1 BOTTLE in 1 CARTON (0573-0169-51) / 180 CAPSULE, LIQUID FILLED in 1 BOTTLE | April 10, 1995 |
| 0573-0169-52 | 0573-0169 | Haleon US Holdings LLC | 1 BOTTLE in 1 CARTON (0573-0169-52) / 200 CAPSULE, LIQUID FILLED in 1 BOTTLE | April 10, 1995 |
| 0573-0169-76 | 0573-0169 | Haleon US Holdings LLC | 1 BOTTLE in 1 CARTON (0573-0169-76) / 160 CAPSULE, LIQUID FILLED in 1 BOTTLE | April 10, 1995 |
| 0573-0169-86 | 0573-0169 | Haleon US Holdings LLC | 1 BOTTLE in 1 CARTON (0573-0169-86) / 100 CAPSULE, LIQUID FILLED in 1 BOTTLE | April 10, 1995 |
| 0573-0169-89 | 0573-0169 | Haleon US Holdings LLC | 1 BOTTLE in 1 CARTON (0573-0169-89) / 160 CAPSULE, LIQUID FILLED in 1 BOTTLE | April 10, 1995 |
| 0573-1769-02 | 0573-1769 | Haleon US Holdings LLC | 50 PACKET in 1 CARTON (0573-1769-02) / 2 CAPSULE, LIQUID FILLED in 1 PACKET | June 1, 2018 |
| 0573-1769-09 | 0573-1769 | Haleon US Holdings LLC | 1 VIAL in 1 BLISTER PACK (0573-1769-09) / 8 CAPSULE, LIQUID FILLED in 1 VIAL | June 1, 2018 |
| 0573-1769-13 | 0573-1769 | Haleon US Holdings LLC | 200 CAPSULE, LIQUID FILLED in 1 BOTTLE (0573-1769-13) | June 1, 2018 |
| 0573-1769-14 | 0573-1769 | Haleon US Holdings LLC | 240 CAPSULE, LIQUID FILLED in 1 BOTTLE (0573-1769-14) | December 1, 2018 |
| 0573-1769-16 | 0573-1769 | Haleon US Holdings LLC | 2 BOTTLE in 1 CARTON (0573-1769-16) / 80 CAPSULE, LIQUID FILLED in 1 BOTTLE | March 28, 2025 |
| 0573-1769-20 | 0573-1769 | Haleon US Holdings LLC | 1 BOTTLE in 1 CARTON (0573-1769-20) / 20 CAPSULE, LIQUID FILLED in 1 BOTTLE | March 8, 2017 |
| 0573-1769-31 | 0573-1769 | Haleon US Holdings LLC | 1 BOTTLE in 1 CARTON (0573-1769-31) / 30 CAPSULE, LIQUID FILLED in 1 BOTTLE | April 1, 2021 |
| 0573-1769-80 | 0573-1769 | Haleon US Holdings LLC | 1 BOTTLE in 1 CARTON (0573-1769-80) / 80 CAPSULE, LIQUID FILLED in 1 BOTTLE | March 8, 2017 |
| 0573-1769-87 | 0573-1769 | Haleon US Holdings LLC | 1 BOTTLE in 1 CARTON (0573-1769-87) / 100 CAPSULE, LIQUID FILLED in 1 BOTTLE | February 1, 2021 |
| 0573-1769-89 | 0573-1769 | Haleon US Holdings LLC | 1 BOTTLE in 1 CARTON (0573-1769-89) / 160 CAPSULE, LIQUID FILLED in 1 BOTTLE | March 8, 2017 |
| 0573-1769-92 | 0573-1769 | Haleon US Holdings LLC | 1 BOTTLE in 1 CARTON (0573-1769-92) / 180 CAPSULE, LIQUID FILLED in 1 BOTTLE | April 1, 2021 |
| 0573-0149 | 0573-0149 | Haleon US Holdings LLC | — | April 10, 1995 |
| 0573-0169 | 0573-0169 | Haleon US Holdings LLC | — | April 10, 1995 |
| 0573-1769 | 0573-1769 | Haleon US Holdings LLC | — | March 8, 2017 |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Identity, ingredients, strengths, forms, routes, labelers, packages |
| Drugs@FDA | FDA | Application, sponsor, submissions, review documents, marketing status |
| Drug Labeling | FDA / NLM | Prescribing information reproduced above |
| FAERS | FDA | Adverse event report counts |
| Enforcement | FDA | Recall records |
Generated September 25, 2026 · 13 sections on this page.